Another study found that miR-590-3p expression is downregulated in MCF-7 and MDA-MB-231 breast cancer cells, and miR-590-3p exerts its antitumor effects (induction of apoptosis and reduction of cell survival) by targeting SIRT1 in breast cancer cells [207]. This evidence concerns the gene SIRT1 and breast carcinoma.